Literature DB >> 21764504

Complications following the use of alloplastic materials in urogynecological surgery.

Karin Renezeder1, Christine E Skala, Stefan Albrich, Heinz Koelbl, Gert Naumann.   

Abstract

STUDY
DESIGN: 118 patients, who were admitted from 2005 to 2008 to our department due to complications following mesh implantation, were included in a retrospective survey. We investigated patient symptoms, findings and subsequent patient management. There was a re-evaluation of symptoms in a follow-up eight weeks after the revision procedure. Data from our urogynecological file archive were used.
RESULTS: The main complaints were de novo urgency, pain and recurrent urinary tract infections. The main findings were mesh erosion and infections including abscess formations and osteomyelitis. Before being admitted to our department, 42 patients (35.6%) had already undergone at least one intervention. Surgery to overcome complications was performed in our unit after an average time of 27 months. In most cases, mesh removal was necessary.
CONCLUSIONS: Surgeons need to be aware of potential mesh complications, which should be managed in referral centres as soon as symptoms arise and should be documented in registers. There is a need for more prospective randomised studies on complications arising from surgery.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21764504     DOI: 10.1016/j.ejogrb.2011.06.015

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

1.  Current Developments and Perspectives on the Diagnosis and Treatment of Urinary Incontinence and Genital Prolapse in Women.

Authors:  G Naumann; H Kölbl
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-03       Impact factor: 2.915

Review 2.  Management of Mesh Complications after SUI and POP Repair: Review and Analysis of the Current Literature.

Authors:  D Barski; D Y Deng
Journal:  Biomed Res Int       Date:  2015-04-20       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.